Study: 26% of C. Diff Patients Received Only Unnecessary Antimicrobials
Researchers studied 246 patients with new-onset CDI diagnosed at Minneapolis Veterans Affairs Medical Center from January 2004 through December 2006. Two infectious disease physicians evaluated the use of non-CDI antimicrobials (those that are inactive against C. diff), which they defined as unnecessary if not fully indicated.
Data showed 57 percent of patients received non-CDI antimicrobials during and/or after their CDI treatment, and 77 percent received at least one unnecessary antimicrobial dose. Twenty-six percent of patients received only unnecessary antimicrobials.
More Articles on C. diff:Quidel Receives FDA Clearance for Handheld Molecular Diagnostic Test for C. Difficile
Illinois Publishes C. Diff, MRSA Data From Lab Tests for First Time
Study: Dog Correctly Detected C. Difficile in Patients
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Spring Creek Surgical Center receives AAAHC accreditation
- From physician to billionaire: Dr. Keith Dunleavy’s net worth tops $1B with healthcare data analytics firm
- 5 most read GI/endoscopy stories: May 16 – May 20
- 6 points of contention between Anthem & Cigna: Will it derail the merger?
- FDA clears Avantis Medical's Third Eye Panoramic for reuse after colonoscopy: 5 notes